{'fraction_non_alphanumeric': 0.018488745980707395, 'fraction_numerical': 0.001607717041800643, 'mean_word_length': 5.80327868852459, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Antimycotic potential of Kawayang tinik against pathogenic fungal species

The importance of discovering and obtaining new, natural and sustainable sources of potential drugs have been the focus of scientific communities due to the emergence of increasing cases of microbial resistance, one of the biggest health threats in our society today. This study aimed to determine the antimycotic potential of Bambusa blumeana (kawayang tinik) specifically its leaf, rhizome, root, inner culm and outer culm extracts using the agar well diffusion assay. Results of the study revealed that all kawayang tinik extracts produced statistically equal size zone of inhibition (ZOI) against Aspergillus niger at 1 mg/ ml concentration while the ethanolic root and leaf extracts showed larger ZOI against Penicillium chrysogenum compared to other kawayang tinik extracts. Furthermore, the results of the antifungal assay showed comparable activity of kawayang tinik extracts to Fluconazole, a pharmaceutically approved antifungal drug, at 1 mg/ml concentration. Phytochemical studies further revealed the presence of alkaloids, tannins, phenols, sterols, triterpenes and flavonoids in its different parts which may support its potential antimycotic properties.